Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

VHIR's researchers identify a protein which predicts kidney cancer in the initial stages and in its prognosis

The study has correlated the presence of the marker –HAVCR-1/KIM1 protein– with the tumor’s diagnosis and prognosis

News

Three thoughts about Women's Day at VHIR

Dr. Anna Messeguer, Dr. María Jesús Cruz and Dr. Fátima Núñez talk about women and science

News

Probable amnestic MCI people are in the highest risk of conversion to dementia

Dr. Mercè Boada from VHIR participates in this study of the ACE Foundation published in 'Journal of Alzheimer's Disease'

News

Vall d'Hebron and B. Braun will investigate a new treatment for burns

Researchers will evaluate the evolution, recovery and tolerability of second-degree burns

News

Dr. Galiñanes talks about research in heart repair therapy in 'El Punt Avui'

The head of group at VHIR is looking for alternatives to the transplantation

News

Dr. Alegre talks about the chronic fatigue syndrome at the TV show ‘Para todos la 2’

VHIR's researchers explains the symptoms and the advices to palliate it

News

Vall d’Hebron celebrated the third edition of the course 'Ventilung' about mechanical ventilation

More than 50 professionals attended the course the 7th and 8th of March

News

World-leading experts review the results of MetaHIT and the advances in the field of digestive disorders

Nearly 300 professionals have participated in the ‘Gut Microbiota for Health’ summit.

News

Clinical trials with positive results publish more and before

The impact factor is the same compared to the negative clinical trials

News

Vall d'Hebron and Fundación Vodafone present a rehabilitation project at the Mobile World Congress

With this application, patients of stroke could do exercise and connect with their doctors from home

News

World-leading experts in gut microbiota celebrate in Madrid the 2nd World Summit

Drs. Azpiroz and Guarner take part in the organization of this congress managed by ESNM

News

VHIR reaches more than 1.000 followers on Twitter

Follow us on @VHIR_ and facebook.com/vhir.org

News

Vall d'Hebron participates in a global study on the effectiveness of new endovascular treatments in patients with ischemic stroke

The conclusions, published at NEJM, offer information about the subgroups that could benefit from the new treatments

News

The Mediterranean diet doesn't protect the ageing of the most common heart surgery

A study of the Cardiology Service at HUVH determines that it doesn’t predict the degeneration of the aortic valve

News

VHIR and OWL collaborate in the search of new biomarkers

The biotechnology company will provide services of metabolomics and lipidomics

News

VHIR participates in the creation of Bioinformatics Barcelona

The aim of the future platform is to become an international point of reference in the field of bioinformatics

News

The new guidelines for management of sepsis insist on the early quantitative recognition and the training of professionals

Dr. Rello from VHIR has participated in the third edition of the recommendations published at 'Critical Care'

News

Transbiomed merges with the biotech company Amadix

The first VHIR’s spin-off has sold all the shares and the new group has increased the capital in 2 million euros